| AKTX Stock | | | USD 1.21 0.09 8.04% |
Akari Therapeutics financial indicator trend analysis is way more than just evaluating Akari Therapeutics PLC prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Akari Therapeutics PLC is a good investment. Please check the relationship between Akari Therapeutics Net Debt and its Other Stockholder Equity accounts. Check out
Trending Equities to better understand how to build diversified portfolios, which includes a position in Akari Therapeutics PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in estimate.
Net Debt vs Other Stockholder Equity
Net Debt vs Other Stockholder Equity Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Akari Therapeutics PLC Net Debt account and
Other Stockholder Equity. At this time, the significance of the direction appears to have weak contrarian relationship.
The correlation between Akari Therapeutics' Net Debt and Other Stockholder Equity is -0.12. Overlapping area represents the amount of variation of Net Debt that can explain the historical movement of Other Stockholder Equity in the same time period over historical financial statements of Akari Therapeutics PLC, assuming nothing else is changed. The correlation between historical values of Akari Therapeutics' Net Debt and Other Stockholder Equity is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Debt of Akari Therapeutics PLC are associated (or correlated) with its Other Stockholder Equity. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Stockholder Equity has no effect on the direction of Net Debt i.e., Akari Therapeutics' Net Debt and Other Stockholder Equity go up and down completely randomly.
Correlation Coefficient | -0.12 |
| Relationship Direction | Negative |
| Relationship Strength | Insignificant |
Net Debt
The total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds.
Other Stockholder Equity
Most indicators from Akari Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Akari Therapeutics PLC current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Trending Equities to better understand how to build diversified portfolios, which includes a position in Akari Therapeutics PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in estimate.
Selling General Administrative is likely to drop to about 7.6
M in 2024.
Tax Provision is likely to drop to about (3
M) in 2024
Akari Therapeutics fundamental ratios Correlations
Click cells to compare fundamentals
Akari Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Akari Therapeutics fundamental ratios Accounts
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Additional Tools for Akari Stock Analysis
When running Akari Therapeutics' price analysis, check to
measure Akari Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Akari Therapeutics is operating at the current time. Most of Akari Therapeutics' value examination focuses on studying past and present price action to
predict the probability of Akari Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Akari Therapeutics' price. Additionally, you may evaluate how the addition of Akari Therapeutics to your portfolios can decrease your overall portfolio volatility.